Reference
Raymakers AJN, et al. Health-related quality of life in oncology drug reimbursement submissions in Canada: A review of submissions to the pan-Canadian Oncology Drug Review. Cancer : 23 Sep 2019. Available from: URL: http://doi.org/10.1002/cncr.32455
Rights and permissions
About this article
Cite this article
Concern over QOL data in cancer drug reimbursement submissions. PharmacoEcon Outcomes News 838, 7 (2019). https://doi.org/10.1007/s40274-019-6252-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-6252-4